Herantis advances HER-096 after successful Phase 1b Parkinson’s trial

8th October 2025 Uncategorised 0

Positive safety and pharmacokinetic data lay foundation for phase 2 study in 2026

More: Herantis advances HER-096 after successful Phase 1b Parkinson’s trial
Source: News